Mark C. Markowski - Concepedia

Author

Mark C. Markowski

Also Known As

Aaron Lebeau, M Markowski, M. C. Markowski, M. Markowski, M.C. Markowski, Mark C Markowski, Mark C. Markowski, Mark Christopher Markowski, Mark Markowski

318

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Medicine University of California, San Francisco University of Washington

About

Mark C. Markowski is an author at Johns Hopkins University specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	682
2	Cell Biology	4	4	157
3	Health Sciences	2	2	72
4	Public Health	2	2	23
5	Engineering	1	1	23

Mark C. Markowski

Publications

Citations

H-Index

Page 1

	Year	Citations
Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors Sarina A. Piha‐Paul, Christine L. Hann, Christopher A. French, JNCI Cancer Spectrum	2019	196
Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies Karen S. Sfanos, Mark C. Markowski, Lauren B. Peiffer, Prostate Cancer and Prostatic Diseases	2018	141
Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA‐repair gene mutations in prostate cancer Pedro Isaacsson Velho, John L. Silberstein, Mark C. Markowski, The Prostate	2018	136
TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer Samuel R. Denmeade, Hao Wang, Neeraj Agarwal, Journal of Clinical Oncology	2021	133
Androgen blocks apoptosis of hormone-dependent prostate cancer cells. Kotohiko Kimura, Mark C. Markowski, Cai Bowen, PubMed UrologyOncologyAndrogen Blocks ApoptosisMedicineApoptosis	2001	97
The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited Matthew P. Deek, Kim Van der Eecken, Ryan Phillips, European Urology	2021	97
Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects Pedro Isaacsson Velho, Fahad Qazi, Sayeedul Hassan, European Urology UrologyGenitourinary CancerMedicineCancer TreatmentProstatic Disease	2018	92
Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer Pedro Isaacsson Velho, Wei Fu, Hao Wang, European Urology UrologyMedicinePharmacologyResistance Mutation (Virology)Pharmacotherapy	2019	91
A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE): A Comparison of Post-abiraterone Versus Post-enzalutamide Cohorts Mark C. Markowski, Hao Wang, Rana Sullivan, European Urology Bipolar Androgen TherapyUrologyMedicineClinical TrialsTreatment Option	2020	81
Inflammatory Cytokines Induce Phosphorylation and Ubiquitination of Prostate Suppressor Protein NKX3.1 Mark C. Markowski, Cai Bowen, Edward P. Gelmann Cancer Research	2008	64

Page 1